Niche Sepsis Solution Alteco Medical's LPS Adsorber targets endotoxemia in sepsis patients, offering a unique add‑on therapy to stabilize patients when standard treatments fall short, presenting a clear entry point for hospital procurement and critical care budgeting.

Global Distribution Existing and planned distribution partnerships (Australia, New Zealand with BTC Health; Chile with Incardia) indicate a scalable channel approach and opportunities to expand with similar regional distributors or hospital groups in other high‑need markets.

Small but Specialized With a lean team and ISO 13485 certification, the company can pivot quickly to support targeted sales efforts, including focused outreach to ICUs, procurement, and clinical champions in sepsis management.

Early Finance Signals Recent funding and a modest loan from a major shareholder suggest growing financial runway for regional market expansion, clinical trials, or expanded regulatory/compliance activities that support larger sales cycles.

Low-Volume, High-Value Annual revenue under $1M and a high‑impact product position enable a value‑based sales approach emphasizing cost‑effectiveness in sepsis care, potential to pursue pilots with key hospital systems and regional distributors.